Vimarsana
Biggest News Aggregation in the World

Ocular Microsurgery News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ocular Microsurgery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ocular Microsurgery Today - Breaking & Trending Today

Pixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the receivership proceedings into liquidation proceedings - Vimarsana News

Pixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the receivership proceedings into liquidation proceedings

Pixium Vision announces the rejection of the sale plan by the Court and the conversion of the receivership proceedings into liquidation proceedings Paris, France, February 2, 2024 – 02:00 p.m....

Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024 - Vimarsana News

Postponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024

Postponement of the decision on the adoption of a sale plan and the opening of judicial liquidation proceedings to January 31, 2024 Paris, France, January 17, 2024 – 5:00 pm  – Pixium...

Decision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings scheduled for January 16, 2024 - Vimarsana News

Decision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings scheduled for January 16, 2024

Decision concerning the adoption of a sale plan and the opening of judicial liquidation proceedings scheduled for January 16, 2024 Paris, France, December 18, 2023 – 7:00 pm  – Pixium...

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD - Vimarsana News

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD

Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMDStudy confirms subretinal prothesis feasible and well-tolerated with no r...

Pixium Vision announces its financial results for H1 2023 and provides update - Vimarsana News

Pixium Vision announces its financial results for H1 2023 and provides update

Pixium Vision announces its financial results for H1 2023 and provides update Post period event: Received shareholder loan of €3 million from BPIFrance and Sofinnova. Extension of the maturity of outstanding notes €1.25 million, Implemented a reverse stock split, exchanging 50 old to 1 current share, applied for and obtained safeguard proceeding, applied for conversion of the safeguard proceeding to a court-ordered receivership and announced the opening of a process to find a buyerCurrent cash r

Source: yahoo.com